For the year ending 2025-12-31, DCOY has $11,056,707 in assets. $5,167,738 in debts. $10,709,937 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash, cash equivalents, and restricted cash | 10,709,937 | |||
| Prepaid expenses and other current assets | 275,223 | |||
| Total current assets | 10,985,160 | |||
| Property and equipment, net | 40,559 | |||
| Other assets | 30,988 | |||
| Total assets | 11,056,707 | |||
| Accounts payable | 940,586 | |||
| Accrued expenses and other current liabilities | 859,442 | |||
| Deferred revenue | 3,225,581 | |||
| Notes payable | 0 | |||
| Due to related party | 139,823 | |||
| Other current liability | 2,306 | |||
| Total current liabilities | 5,167,738 | |||
| Total liabilities | 5,167,738 | |||
| Common stock of 0.0001 par value 100,000,000 shares authorized 531,968 and 8,006 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 53 | |||
| Additional paid-in capital | 100,331,014 | |||
| Accumulated deficit | -94,442,098 | |||
| Total stockholders' equity | 5,888,969 | |||
| Total liabilities, and stockholders' equity | 11,056,707 | |||
Decoy Therapeutics Inc. (DCOY)
Decoy Therapeutics Inc. (DCOY)